The Reproductive Microbiome & Perinatal Health Outcomes
- Conditions
- PreTerm BirthHuman Gastrointestinal MicrobiotaHuman MicrobiotaMetabolomics
- Interventions
- Other: Survey, Sample collection
- Registration Number
- NCT02948192
- Lead Sponsor
- Baylor Research Institute
- Brief Summary
Pregnant African American women between 18 and 45 years of age will be enrolled at 20 weeks of gestation or less. Biological specimens (vaginal swabs, rectal swab) will be collected at enrollment, 23-24 weeks, at 28-29 weeks, and at the onset of labor. A urine sample will be obtained at entry and at the time of delivery for metabolomic analysis. Participants will also collect a dietary survey at entry, 23-24 weeks, and 28-29 weeks. The biological specimens will then be analyzed for their microbiomial profile. This will then be correlated with the timing of their delivery as well as other comorbidities such as obesity, hypertension, and diabetes.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- Female
- Target Recruitment
- 55
- Able to read and understand English, full decision making capabilities, African American (self-identified), Pregnant, At 20 weeks or less of gestation, Singleton pregnancy, 18-45 years of age
- Race other than African American, Advanced gestational age (>20 weeks), Multiple gestations, Less than 18 years or greater than 45 years of age.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Preterm Delivery Survey, Sample collection African american women who present for prenatal care who experience spontaneous preterm birth Term delivery Survey, Sample collection African american women who present for prenatal care who experience term birth
- Primary Outcome Measures
Name Time Method Preterm Delivery 36 weeks Onset of preterm labor with subsequent spontaneous preterm birth
- Secondary Outcome Measures
Name Time Method Microbiome profile 36 weeks Evaluation of characteristics of the vaginal microbiome in cohorts
Medical comorbidities 36 weeks Evaluation of the comorbidities present in the cohort
Metabolomic profile 36 weeks Evaluation of characteristics of the metabolomic products present in cohort
Term delivery 36 weeks Delivery at term
Gut Microbiome profile 36 weeks Evaluation of the characteristics of the gastrointestinal microbiome in cohorts